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Abstract
Cellular adhesion and spreading are critical components involved in the processes of cell and tissue development, and
immune responses in molluscs, but at present, little is known regarding the signaling pathways involved in these basic cellular
functions. In the present study, the molluscan Biomphalaria glabrata embryonic (Bge) cell line was used as an in vitro model
to study the signal transduction pathways regulating molluscan cell adhesion and spreading behavior. Western blot analysis
using antibodies specific to mitogen-activated protein kinase (MAPK) revealed the presence of an MAPK-like
immunoreactive protein in Bge cells, that was phosphorylated upon exposure to phorbol myristate acetate (PMA).
Moreover, Bge cell treatment with inhibitors of protein kinase C (PKC), Ras and MAPK kinase (Mek) suppressed PMA-
induced expression of activated MAPK, suggesting that PKC-, Ras- and Mek-like molecules may be acting upstream of
MAPK. Similarly, in vitro Bge cell-spreading assays were performed in conjunction with the same panel of inhibitors to
determine the potential involvement of PKC, Ras and Mek in cellular adhesion/spreading. Results revealed a similar pattern
of inhibition of cell-spreading behavior strongly implying that the Bge cell spreading also may be regulated through a
MAPK-associated signal transduction pathway(s) involving proteins similar to PKC, Ras and Mek. ß 2001 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Cell adhesion and spreading are essential for devel-
opment, maintenance and survival in all multicellular
organisms, and are directly involved in such process-
es as embryogenesis, morphogenesis and tissue orga-
nization, and immune responses [1^3]. Although,
there exists a substantial body of knowledge regard-
ing the molecular mechanisms underlying the regula-
tion of mammalian cell adhesive behavior, very little
is known about the same regulatory mechanisms in
molluscs. Previous studies have demonstrated that
cells of the molluscan Biomphalaria glabrata embry-
onic (Bge) cell line could be inhibited in their in vitro
spreading behavior by treatment with the tetrapep-
tide RGDS [4]. RGDS inhibition implied the involve-
ment of integrin adhesion receptors and indeed, in
subsequent studies, a L1-like integrin subunit cDNA
homologue was cloned from Bge cells [4]. Few inver-
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tebrate integrin homologues have been discovered to
date [5] and therefore our knowledge of integrin-
mediated adhesion and signaling mechanisms has
stemmed primarily from mammalian cell research.
Participation of integrin receptors in cell adhesion
and spreading has been well established in numerous
mammalian cell types [6^8]. The study of integrin
mediated cellular signaling associated with adhesive
behavior likewise has been extensively studied in
mammalian systems, and results show that signaling
pathways can vary considerably depending on cell
type and integrin subunit combination [9]. Despite
the potential complexity of signal transduction net-
works, it has frequently been demonstrated that pro-
tein kinase C (PKC) and mitogen-activated protein
kinase (MAPK) act downstream of integrin activa-
tion, often in a signaling cascade regulating mamma-
lian cell spreading (Fig. 1) [10^13].
Analogous to mammalian systems, recent studies
demonstrate a similar role for integrins in inverte-
brate cell adhesion and migration; for example, the
¢nding by Martin-Bermudo et al. [14] that Drosophi-
la cells migrate via PS integrin receptors. However,
integrin-mediated signaling, and signaling pathways
in general, in invertebrates remains a comparatively
unexplored area. Nevertheless, one may hypothesize
that invertebrate signal transduction involves pro-
teins homologous to those found in mammalian sys-
tems. In support of this hypothesis, there is a grow-
ing accumulation of literature reporting homologous
signal transduction molecules in invertebrates, in-
cluding MAPK, focal adhesion kinase (FAK),
Grb2, and Ras homologues in Drosophila and Cae-
norhabditis elegans [15^18]. In addition, inhibition
studies have detected the activity of speci¢c signaling
molecules in several molluscs, including arachidonic
acid (AA), cyclic adenosine monophosphate (cAMP),
inositol triphosphate (IP3), MAPK, protein kinase A
(PKA), PKC, and phospholipase A2 (PLA2) [19^23].
The aims of the present study were twofold; ¢rst,
to examine whether proteins similar to vertebrate
signal transduction molecules such as PKC and
MAPK might be present in Bge cells, and second,
to investigate which signaling molecules and path-
ways regulate Bge cell spreading. These objectives
were carried out using selective inhibitors to a variety
of signal transduction molecules, including calphos-
tin C and chelerythrine chloride to block PKC, Ras
inhibitory peptide and FTase Inhibitor I to block
Ras, and PD 98059 to block Mek.
2. Materials and methods
2.1. Biomphalaria glabrata embryonic (Bge) cell
maintenance and isolation
Bge cells, originally isolated by Hansen [24], were
obtained from American Type Culture Collection
(ATCC CRL 1494). Cells were maintained at 26‡C
at normal atmospheric conditions in complete Bge
cell medium [24], supplemented with 10% heat-inac-
tivated fetal bovine serum (FBS; Summit Biotechnol-
ogy, Ft. Collins, CO) and antibiotics (100 U/ml pen-
icillin G and 0.05 g/ml streptomycin sulfate). Bge
cells, grown to near con£uence in 75-cm2 tissue cul-
ture £asks, were ¢rst rinsed with cold Chernin’s bal-
anced salt solution, pH 7.2 (CBSS) [25], followed by
addition of fresh cold (4‡C) CBSS and the suspen-
sion of attached Bge cells by gentle pipeting of bu¡-
er. Suspended cells were centrifuged at 1500 rpm
(Centrifuge 5810 R, Eppendorf, Brinkmann Instru-
ments, Westburg, NY) for 3 min at 4‡C, resuspended
in fresh cold CBSS and counted using a hemocytom-
eter. All chemicals used in this study were purchased
from Sigma^Aldrich Chemical Co., St. Louis, MO,
unless otherwise indicated.
2.2. Inhibitors
A variety of speci¢c inhibitors were employed in
the study: calphostin C and chelerythrine chloride
were used to inhibit the regulatory and catalytic do-
mains, respectively, of protein kinase C (PKC). Cal-
phostin C binds to the diacylglycerol (DAG) binding
site and selectively inhibits DAG-sensitive PKC iso-
zymes [26], while chelerythrine chloride is a nonspe-
ci¢c inhibitor which competitively inhibits the phos-
phate acceptor site and noncompetitively inhibits the
ATP binding site [27]. Two inhibitors of Ras were
utilized; ¢rstly Ras inhibitory peptide (Val-Pro-Pro-
Pro-Val-Pro-Pro-Arg-Arg-Arg), which hinders Ras
activation by preventing the formation of a Grb2-
SOS complex [28] and secondly, FTase Inhibitor I
(Calbiochem Novabiochem Corp., San Diego, CA),
which acts by blocking farnesylation of the Ras pro-
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tein thus stopping its translocation to the plasma
membrane [29]. Finally, PD 98059 (Calbiochem No-
vabiochem) was included to inhibit mitogen-acti-
vated protein kinase kinase (MAPKK or Mek), by
preventing the activation of Mek by Raf, a serine/
threonine protein kinase [30].
2.3. MAPK detection and its activation by PMA
Antibodies speci¢c to MAPK and activated (di-
phosphorylated) MAPK were used in Western blot
analyses (see detailed description below) to detect
immunoreactive MAPK in Bge cells under condi-
tions of cellular activation and in the presence of
signal transduction inhibitory drugs.
In initial PMA-activation experiments, Bge cells
were isolated, washed and counted following the pro-
tocols described, and 1.5U105 cells in 50 Wl CBSS
per well were aliquoted into wells of a 96-well tissue
culture plate (Costar, Corning, NY). Cells were al-
lowed to spread for 3 h, followed by centrifugation
at 1000 rpm for 1 min at room temperature and
removal of supernatant (Centrifuge 5810 R, Eppen-
dorf, Brinkmann Instruments). Following an addi-
tional 30-min incubation in CBSS, cells were treated
with either 50 Wl 500 nM phorbol 12-myristate 13-
acetate (PMA) in CBSS (resulting in a ¢nal concen-
tration of 250 nM PMA) or 50 Wl CBSS (negative
control). After 10 min incubation, the plate was cen-
trifuged as before, the supernatant removed, and
cells were lysed with 2Usodium dodecyl sulfate^
polyacrylamide gel electrophoresis (SDS^PAGE) re-
ducing bu¡er diluted 1:1 with CBSS. Samples were
boiled for 5 min and stored at 320‡C until Western
blot analysis.
2.4. Inhibition of PMA-mediated MAPK activation
In order to test the hypothesis that MAPK activa-
tion is regulated upstream by PKC or Ras signal
transduction pathways, various drugs targeting spe-
ci¢c signal pathway components were used to block
PMA-mediated activation of Bge cell MAPK. A sim-
ilar protocol as outlined above was used. Brie£y,
1.5U105 cells were aliquoted into wells of a 96-well
tissue culture plate and allowed to spread for 3 h.
The plate was then centrifuged, the supernatant re-
moved and the cells were treated with either 50 Wl
inhibitor or 50 Wl CBSS (negative control) for 30
min. Following treatment cells were stimulated with
either 50Wl 500 nM PMA or 50 Wl CBSS for 10 min.
Plates were then centrifuged as before, the superna-
tants removed, and cells were lysed with 2USDS^
PAGE reducing bu¡er diluted 1:1 with CBSS. Sam-
ples were boiled for 5 min and stored at 320‡C until
Western blot analysis. One exception to the protocol
described above regards the use of FTase Inhibitor I,
whereby cells were aliquoted and allowed to spread
in the presence of inhibitor for 3 h, prior to stimu-
lation with PMA. This 3 h pre-PMA incubation pe-
riod was carried out in order to deplete levels of
previously farnesylated, membrane bound Ras pro-
tein.
Viability of control and drug treated cells was
tested using the trypan blue exclusion method, in
which cells were aliquoted and allowed to spread
for 3 h, followed by replacement of supernatant
with either 50 Wl inhibitor or CBSS control. After
30 min, trypan blue was added to the wells and the
percentage viable (unstained) cells calculated.
2.5. Western blot analysis
After solubilization of cells in SDS^PAGE reduc-
ing bu¡er, samples were loaded onto a 10% polyac-
rylamide gel, separated at 150 mV for 45 min, and
subsequently transferred to Hybond ECL nitrocellu-
lose membrane (Amersham Pharmacia Biotech, UK)
at 100 mA for 30 min. Membranes were incubated
overnight at 4‡C in a blocking solution of TBS (10
mM Tris^HCl, 100 mM NaCl, 0.2% Tween 20, pH
7.5) containing 0.1% bovine serum albumin. To de-
tect MAPK (both activated and nonactivated forms),
membranes were incubated with a polyclonal anti-
MAPK (Erk 1/2, Sigma^Aldrich) antibody at a dilu-
tion of 1:20 000 for 2 h. Membranes were then
washed 2U15 min in TBS, and incubated in a horse-
radish peroxidase (HRP)-conjugated goat anti-rabbit
IgG (H+L) secondary antibody (Promega Corp.,
Madison, WI) at a dilution of 1:25 000 for 1 h. To
detect activated (diphosphorylated) MAPK, mem-
branes were incubated with an anti-diphosphorylated
MAPK (Erk 1/2, Sigma^Aldrich) monoclonal pri-
mary antibody for 2 h at a dilution of 1:100 000.
The latter antibody speci¢cally recognizes activated
or diphosphorylated (Thr183 and Tyr185) MAPK (Erk
BBAMCR 14789 21-9-01
J.E. Humphries et al. / Biochimica et Biophysica Acta 1540 (2001) 243^252 245
1/2) only. After 2U15-min TBS washes, the blots
were incubated in an HRP-conjugated rabbit anti-
mouse IgG (H+L) secondary antibody (Pierce, Rock-
ford, IL) at a dilution of 1:20 000 for 1 h. Mem-
branes were again washed 2U15 min in TBS. Sub-
sequently, all blots were incubated 5 min in 10 ml
SuperSignal West Pico Chemiluminescent Substrate
(Pierce), followed by exposure to radiographic ¢lm
for approximately 30 sec. The ¢lm was developed in
Kodak GBX developer, washed in double-distilled
water, then ¢xed in Kodak GBX ¢xer (Eastman Ko-
dak Co., NY). A nerve growth factor (NGF)-treated
PC12 cell extract (Promega) was included as a pos-
itive control, as 42/44 kDa MAPK has been shown
Fig. 1. Diagram showing hypothetical signaling pathway, based on mammalian signaling systems, which might regulate Biomphalaria
glabrata embryonic (Bge) cell spreading. Following integrin^ECM binding, receptor clustering and activation, intracellular diacylglycer-
ol (DAG) levels increase leading to binding and activation of protein kinase C (PKC), which in turn phosphorylates (activates) focal
adhesion kinase (FAK). FAK, upon autophosphorylation, combines with the adapter protein, Grb2, leading to the formation of a
complex with the guanine nucleotide exchange factor, SOS. This complex can activate Ras through the exchange of GTP (guanine tri-
phosphate) for GDP (guanine diphosphate), which then leads to a Ras-mediated recruitment of Raf to the plasma membrane trigger-
ing a subsequent cascade of kinase activation steps including the successive phosphorylation/activation of Raf, Mek and ¢nally mito-
gen-activated protein kinase (MAPK) through phosphorylation of its threonine and tyrosine residues. Activated MAPK can then act
upon either nuclear targets such as Elk-1, to regulate transcription, or alternatively, on cytoplasmic targets such as phospholipase A2,
to induce cell spreading.
BBAMCR 14789 21-9-01
J.E. Humphries et al. / Biochimica et Biophysica Acta 1540 (2001) 243^252246
to be activated (diphosphorylated) following NGF
treatment [31]. Each experiment was repeated four
times.
2.6. Cell-spreading assays
Approximately 1U104 Bge cells, isolated and
enumerated as described previously, were aliquoted
in triplicate to wells of 24-well Te£on-printed glass
microslides (Cel-line Associates, New¢eld, NJ). Cells
were allowed to attach and spread 30 min in the
presence of either; an inhibitor over a range of con-
centrations or CBSS saline control. The inhibitors
used, and the range of concentrations tested, were
as follows: calphostin C (0.5^20 nM), chelerythrine
chloride (5^100 nM), Ras inhibitory peptide (1^100
WM), FTase Inhibitor I (1^100 WM) and PD 98059
(100^750 WM). Cells were then ¢xed in 4% paraform-
aldehyde (PFA) for 5 min, mounted in CBSS, and
examined at 400U using an Olympus BH-2 phase-
contrast microscope. A minimum of 200 cells per
well were counted and the percentage of spread cells
was calculated. Four independent replicates of each
experiment were performed. Data were then analyzed
by one-way analysis of variance followed by Dun-
nett’s post hoc test using the software package
Graph Pad Prism version 3.0. Viability of control
and treated cells was assessed via the trypan blue
exclusion method as previously described.
3. Results
3.1. MAPK assay: detection of MAPK and its
activation in Bge cells
Using the general anti-MAPK polyclonal anti-
body, a single protein band of approximately 42
kDa molecular mass was detected, in both the con-
trol samples incubated in CBSS alone and in cell
samples stimulated with 250 nM PMA (Fig. 2a).
The monoclonal anti-MAPK antibody, which specif-
ically recognizes activated or diphosphorylated
MAPK, cross-reacted with a single protein band of
the same molecular mass only in samples of PMA-
stimulated Bge cells and not in the control lanes
representing cells treated with CBSS alone (Fig.
2b). Both antibodies also recognized the activated
MAPK standard, which comigrated with the Bge
cell MAPK-like protein band. The two protein bands
visible in Fig. 2b (lane 1) represent ERK1 and ERK2
(44 and 42 kDa) of the MAPK family.
In order to investigate the possible cell signaling
pathways responsible for PMA-mediated MAPK ac-
tivation, cells were stimulated with PMA after pre-
incubation with inhibitors to various signal transduc-
tion molecules. All the inhibitors employed were
capable of reducing PMA-stimulated MAPK-like
protein phosphorylation at di¡erent concentrations.
Calphostin C was inhibitory at concentrations of
1 nM and above (Fig. 3a), whilst concentrations
equal to or greater than 10 nM chelerythrine chloride
signi¢cantly inhibited the activation of MAPK (Fig.
3b). Incubation of Bge cells with 50 WM or greater
Ras inhibitory peptide also signi¢cantly inhibited
MAPK phosphorylation, while it took FTase Inhib-
itor I twice the concentration to bring about the
Fig. 2. Western blots demonstrating PMA-induced MAPK acti-
vation in Bge cells. Cells were allowed to spread for 3 h, then
incubated with either control CBSS or 250 nM PMA for 10
min. Cells were lysed and proteins separated by SDS^PAGE,
and immunoblotted as described in the text. In (a), proteins
were detected with a polyclonal antibody that recognizes
MAPK irrespective of phosphorylation status, whereas in (b)
proteins were detected with a monoclonal antibody that speci¢-
cally recognizes diphosphorylated (activated) MAPK only. Both
blots are of an identical layout. Lane 1, positive standard from
NGF-treated PC12 cells ; lanes 2,3, cells incubated in control
bu¡er, CBSS; lanes 4,5, cells treated with 250 nM PMA.
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same level of MAPK inhibition (Fig. 4a,b). PD
98059, which blocks Mek, also inhibited MAPK
phosphorylation, but only at comparatively high
concentrations of 50 WM or greater (Fig. 5). Viability
of drug-treated cells did not di¡er signi¢cantly from
cells under control conditions, con¢rming that the
inhibition of MAPK phosphorylation was induced
by the di¡erent drugs, and not an artifact of cell
death.
3.2. Bge cell-spreading assays
All inhibitors employed in the study signi¢cantly
reduced Bge cell spreading although in varying de-
grees depending on inhibitor concentrations. On
comparison, the inhibitor concentrations required
to elicit an e¡ect on Bge cells was found to corre-
spond with those used in mammalian systems [28^
30,32,33]. Bge cells responded in a typical dose-de-
pendent manner to a majority of the inhibitors with
the exception of the Ras inhibitory peptide, which
did not exert a signi¢cant e¡ect on spreading until
the highest concentration was reached, at which
point cell spreading was almost completely inhibited.
The most potent inhibitor was found to be the PKC
inhibitor, calphostin C, for which signi¢cant inhibi-
tion of spreading was seen at concentrations as low
as 0.5 nM (P9 0.05) (Fig. 6a). Chelerythrine chloride,
Fig. 5. E¡ect of Mek inhibitor on MAPK phosphorylation.
Cells were allowed to spread for 3 h, then incubated with either
control CBSS (lanes 1^4) or the Mek inhibitor PD 98059 (100
WM) (lanes 5,6) for 30 min. Cells were subsequently stimulated
with either CBSS (lanes 1,2) or 250 nM PMA (lanes 3^6). Cells
were subjected to SDS^PAGE/Western blotting with an anti-di-
phosphorylated MAPK monoclonal antibody.
Fig. 4. E¡ect of Ras inhibitors on MAPK phosphorylation.
Following cell spreading for 3 h in CBSS, they were incubated
with either control CBSS (lanes 1^4), or Ras inhibitory peptide
(100 WM) (lanes 5,6) for 30 min (a). In the case of FTase Inhib-
itor I (500 WM) (b), treated cells were allowed to spread for 3 h
in the presence of the inhibitor prior to PMA stimulation. Cells
were then stimulated with either CBSS (lanes 1,2) or 250 nM
PMA (lanes 3^6). Cells were lysed and proteins subjected to
SDS^PAGE/Western blotting, with an anti-diphosphorylated
MAPK monoclonal antibody.
Fig. 3. E¡ect of PKC inhibitors on MAPK phosphorylation.
Cells were allowed to spread for 3 h in CBSS, then incubated
with either control CBSS (lanes 1^4) or a PKC inhibitor (lanes
5,6) for 30 min. (a) Calphostin C (5 nM), (b) chelerythrine
chloride (10 nM). Cells were then stimulated with either CBSS
(lanes 1,2) or 250 nM PMA (lanes 3^6), followed by protein
separation by SDS^PAGE, and Western blotting with an anti-
diphosphorylated MAPK monoclonal antibody.
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the other PKC inhibitor, exerted a signi¢cant inhib-
itory e¡ect on cell spreading with a lowest signi¢cant
inhibitory concentration (LSIC) of 25 nM (P9 0.01)
(Fig. 6b). As shown in Fig. 7a,b, Bge cells responded
to both Ras inhibitors but with di¡erent behavioral
patterns. Spreading was gradually inhibited in the
presence of FTase Inhibitor I starting at 1 WM with
maximum spreading inhibition attained by 50 WM. In
contrast, no signi¢cant inhibitory e¡ect was seen
with the Ras inhibitory peptide from concentrations
from 1 to 50 WM. However at 100 WM Bge cell
spreading was reduced from 84.4% in the CBSS con-
trol to 7.9% in peptide-treated cells (Fig. 7a). Finally,
similar to the Ras inhibitory peptide, the minimum
inhibitory dose for PD 98059 was 100 WM (Fig. 8),
although the e¡ect was much less than Ras inhibi-
tory peptide at the same concentration. Bge cells ex-
posed to 100 WM Ras inhibitory peptide exhibited
7.9% spreading compared to 51.2% with 100 WM
PD 98059. It is important to note that results of
Bge cell viability assays demonstrated that the reduc-
tion in cell spreading was not due to drug-induced
cytotoxic e¡ects of the inhibitors employed in these
experiments.
4. Discussion
Very little is known about speci¢c signaling mole-
cules and pathways in cells of the gastropod B. glab-
rata, although a number of recent studies are
amongst the ¢rst to bridge this void. Hertel et al.
Fig. 7. Histogram showing e¡ect of Ras inhibitors on Bge cell
spreading. Cells were incubated in either control CBSS or a
Ras inhibitor, Ras inhibitory peptide at 1^100 WM (a) or FTase
Inhibitor I at 1^100 WM (b), for 30 min before ¢xation and cal-
culation of percentage spread cells. Results are presented as
mean þ S.E., n = 4. *P9 0.05, **P9 0.01.
Fig. 6. Histogram showing e¡ect of PKC inhibitors on Bge cell
spreading. Cells were incubated in either control CBSS or a
PKC inhibitor, calphostin C at 0.5^10 nM (a) or chelerythrine
chloride at 5^100 WM (b), for 30 min before ¢xation and calcu-
lation of percentage spread cells. Results are presented as
mean þ S.E., n = 4. *P9 0.05, **P9 0.01.
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[34] observed cell rounding and intracellular calcium
transients when B. glabrata hemocytes (circulating
phagocytic cells) were exposed to larval Echinostoma
paraensei excretory-secretory products, while treat-
ment with PMA induced calcium transients without
rounding. This implies that Biomphalaria cells are
capable of signaling through calcium £uxes, and
modulating the cytoskeletal architecture of the cell
in response to chemical stimuli. In addition, a recep-
tor for activated protein kinase C (RACK) has also
been identi¢ed in B. glabrata, and detected immuno-
cytochemically in both hemocytes and Bge cells [35].
Therefore, the present study focused on identifying
potential signaling molecules in the molluscan Bge
cell line, and secondly, to determine whether the
MAPK signal transduction pathway(s) may be in-
volved in regulating in vitro cell spreading.
As a L1-like integrin subunit has been identi¢ed in
Bge cells [4], it was subsequently hypothesized that
Bge cells might possess some of the signaling mole-
cules known to act downstream of integrin activation
in mammalian cells. Mitogen-activated protein ki-
nase (MAPK), of the serine/threonine protein kinase
family, is frequently cited as a primary participant in
integrin receptor mediated signal transduction [36^
38] and, therefore, it was hypothesized that a
MAPK-like protein may be present in Bge cells, as
well as a protein kinase C (PKC) intracellular signal-
ing system involved in regulating MAPK activation.
Results of Western blot analysis employing speci¢c
MAPK antibodies revealed the presence of an immu-
noreactive MAPK-like molecule with a molecular
mass of 40^44 kDa, in close proximity to the 44
and 42 kDa ERKs 1 and 2 [39]. Moreover, as PD
98059 is known to inhibit MAPKK or Mek, which
directly catalyzes MAPK diphosphorylation, inhibi-
tion of Bge cell MAPK activation by PD 98059 fur-
ther supports the presence of a MAPK-like protein
in Bge cells.
In order to better understand the function of Bio-
mphalaria MAPK, the signaling molecules and path-
ways that might be acting upstream of MAPK, reg-
ulating its activation, were investigated. Western blot
analyses showed that MAPK could be activated/
phosphorylated following PMA treatment, which is
evident of a PKC signaling pathway since PMA is a
diacylglycerol (DAG) analogue that is known to ac-
tivate DAG-sensitive PKC isozymes [40]. Further-
more, MAPK phosphorylation was inhibited upon
incubation with very low concentrations of speci¢c
PKC inhibitors such as calphostin C and chelerythr-
ine chloride; for example inhibitory concentrations
for calphostin C (0.5 nM) were approximately 400
times less than required to block human neutrophil
adhesion [33]. Calphostin C acts by interfering with
DAG binding to the cysteine-rich (C1) regulatory
domain of PKC [26], while chelerythrine chloride
targets the PKC catalytic site, but is not DAG-spe-
ci¢c [27]. Thus calphostin C inhibition of PMA-
mediated activation of MAPK in Bge cells suggests
that the PKC-like protein in Bge cells is probably
closely related structurally to a DAG-sensitive PKC
isozyme(s). Upon discovering that MAPK could be
activated by PMA, presumably through a PKC path-
way, additional inhibitors were used to investigate
which signal transduction molecules might also be
involved. PMA-induced MAPK phosphorylation
was reduced following treatment with Ras inhibitory
peptide, FTase Inhibitor I and PD 98059, implying
Ras and Mek may also act upstream of MAPK in
this PKC/MAPK signaling cascade.
To further characterize the functional role of
MAPK, and speci¢cally its involvement in the regu-
lation of cellular spreading, in vitro cell-spreading
assays in conjunction with the same panel of speci¢c
inhibitors of signal transduction molecules were per-
formed. The cumulative inhibition pro¢les demon-
strated that proteins similar to PKC, Ras and Mek
Fig. 8. Histogram showing e¡ect of Mek inhibitor, PD 98059
on Bge cell spreading. Cells were incubated in either control
CBSS or PD 98059, at 50^750 WM for 30 min before ¢xation
and calculation of percentage spread cells. Results are presented
as mean þ S.E., n = 4. *P9 0.05, **P9 0.01.
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also regulate spreading in Bge cells. As Mek acts
directly upstream of MAPK in the PKC/MAPK sig-
naling cascade, inhibition of spreading by PD 98059
(Mek inhibitor) also implicates MAPK involvement
in cell-spreading behavior. Our ¢ndings are consis-
tent with mammalian cell studies in which PKC and
Mek activation of MAPK were responsible for me-
diating cell spreading in a number of cell lines. For
example, the spreading behavior of a colon carcino-
ma cell line was enhanced upon PMA treatment, and
displayed sensitivity to PKC inhibitors [11] while the
Mek inhibitor UO126 hindered spreading of rat ¢-
broblasts [41].
As mentioned previously, recent studies have sug-
gested that Bge cell spreading is regulated through an
integrin-like receptor(s) [4]. This ¢nding is supported
by a growing body of literature that indicates similar
integrin receptor involvement in cell adhesive and
spreading behavior in a variety of mammalian cell
types [6,8,42]. Furthermore, both PKC and MAPK
are also reported to act downstream of integrin-
mediated signaling, as observed in breast cancer
and ¢brosarcoma cells, where plasminogen activation
of MAPK occurs through a L1 integrin, activating
Ras and Mek [43]. PKC/MAPK regulation of integ-
rin-mediated signal transduction parallels that ob-
served in Bge cells, where the current data strongly
implies regulation of cell-spreading behavior through
a PKC/MAPK signaling pathway. A hypothetical
pathway delineating regulation of Bge cell spreading
is presented here whereby, spreading is initiated by
integrin engagement and clustering, followed by ac-
tivation of PKC by DAG (Fig. 1). FAK is activated
by PKC and, after autophosphorylation, is able to
bind Grb2 by its SH2 domain. Importantly, inhibi-
tion of MAPK activation and Bge cell spreading by
the Ras inhibitory peptide suggests the presence of a
molluscan Grb2/SOS-like mechanism. According to
this mechanism, an adapter protein, Grb2 carries
SOS to Ras, which is activated by the exchange of
GTP for GDP [44]. Ras may then activate Raf,
which in turn phosphorylates Mek, which phosphor-
ylates MAPK on Thr183 and Tyr185. Induction of cell
spreading is presumed to be mediated by MAPK
activation of phospholipase A2 (PLA2), resulting in
an increase in arachidonic acid (AA) levels [45].
The inhibitors employed in the present study have
been used in numerous similar studies [30,32^34]
and, consequently have been subjected to thorough
evaluation of inhibitory mechanisms. However, cau-
tion has been applied when interpreting the present
inhibitor studies since the observation of an inhibi-
tory e¡ect does not prove that the drug is acting by
the same mechanism as in other diverse systems. To
add needed evidence in support of our Bge cell in-
hibitor experiments, future studies will include the
identi¢cation and characterization of Biomphalaria
signal transduction molecules at the molecular level.
For example, recently, we have cloned a partial
cDNA sequence encoding a MAPK-like protein in
Bge cells (J.E. Humphries, T.P. Yoshino, unpub-
lished data).
In conclusion, the results of this study suggest that
molluscan B. glabrata embryonic cells possess an
MAPK-like protein and that PKC- and/or Ras-
like signal transduction molecules may regulate its
activation. Secondly, these same signaling molecules
and their pathways may be responsible for regulating
in vitro Bge cell spreading. Bge cell spreading prob-
ably is not governed by a single, linear pathway but
more likely is under the regulation of an intricate
signaling network, in which multiple signaling path-
ways would interact with each other, transferring
signals received from various receptor^ligand inter-
actions. Further detailed studies are required to elu-
cidate the exact mechanisms regulating Bge cell
spreading, ultimately providing an insight into cell
and tissue development and organization in molluscs.
This is the ¢rst demonstration of PKC, Ras and
MAPK-like signaling molecules in the snail, B. glab-
rata. It is of great interest to explore the level of
homology and conservation between B. glabrata sig-
naling molecules and those already characterized
from vertebrates, at both the structural and function-
al levels.
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